Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays.

Hande KızılocakClara Lana YukhtmanElizabeth Marquez-CasasJeanie LeeJennifer DonkinGuy Young

Published in: Therapeutic advances in hematology (2019)

The TGA can be utilized to support decision-making in patients on emicizumab undergoing major surgery to both predict efficacy and potentially minimize the risk of thrombotic events.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
minimally invasive
patients undergoing
prognostic factors
peritoneal dialysis
early onset
coronary artery bypass
high throughput
patient reported outcomes
coronary artery disease
acute kidney injury
surgical site infection